These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28400027)

  • 1. Socioeconomic Status as a Predictor of Mortality in Patients Admitted With Atrial Fibrillation.
    Kargoli F; Shulman E; Aagaard P; Briceno DF; Hoch E; Di Biase L; Fisher JD; Gross J; Kim SG; Krumerman A; Ferrick KJ
    Am J Cardiol; 2017 May; 119(9):1378-1381. PubMed ID: 28400027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighbourhood socioeconomic position and risks of major chronic diseases and all-cause mortality: a quasi-experimental study.
    Kim D; Glazier RH; Zagorski B; Kawachi I; Oreopoulos P
    BMJ Open; 2018 May; 8(5):e018793. PubMed ID: 29780025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of High-Sensitivity Troponin I to Predict Outcome in Patients With Newly Detected Atrial Fibrillation.
    Kim BS; Kwon CH; Chang H; Kim SH; Kim HJ; Hwang HK; Chung SM
    Am J Cardiol; 2020 Mar; 125(5):744-750. PubMed ID: 31883678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
    Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
    Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study.
    Merkin SS; Coresh J; Diez Roux AV; Taylor HA; Powe NR
    Am J Kidney Dis; 2005 Aug; 46(2):203-13. PubMed ID: 16112038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic status and COPD among low- and middle-income countries.
    Grigsby M; Siddharthan T; Chowdhury MA; Siddiquee A; Rubinstein A; Sobrino E; Miranda JJ; Bernabe-Ortiz A; Alam D; Checkley W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2497-2507. PubMed ID: 27785006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and resource utilization in ST-elevation myocardial infarction in the United States: evidence for socioeconomic disparities.
    Agarwal S; Garg A; Parashar A; Jaber WA; Menon V
    J Am Heart Assoc; 2014 Nov; 3(6):e001057. PubMed ID: 25399775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHA₂DS₂-VASc scores predict mortality after hospitalization for atrial fibrillation.
    Apiyasawat S; Tangcharoen T; Wisaratapong T; Yamwong S; Wiboonpolprasert S; Sritara P
    Int J Cardiol; 2015 Apr; 185():293-6. PubMed ID: 25819735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden.
    Zöller B; Li X; Sundquist J; Sundquist K
    Europace; 2013 Aug; 15(8):1119-27. PubMed ID: 23447572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Sundquist J; Sundquist K
    J Cardiol; 2018 Jul; 72(1):26-32. PubMed ID: 29358024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.
    Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Sørensen HT
    Eur J Heart Fail; 2016 May; 18(5):490-9. PubMed ID: 26868921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter.
    Hagengaard L; Andersen MP; Polcwiartek C; Larsen JM; Larsen ML; Skals RK; Hansen SM; Riahi S; Gislason G; Torp-Pedersen C; Søgaard P; Kragholm KH
    Eur Heart J Qual Care Clin Outcomes; 2021 May; 7(3):295-303. PubMed ID: 31560375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
    Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
    BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.
    Wändell P; Carlsson AC; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Jan; 202():776-81. PubMed ID: 26474468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.